江蘇華辰(603097.SH):擬斥資約20億元投建新能源電力裝備產業基地項目
格隆匯11月27日丨江蘇華辰(603097.SH)公佈,為進一步擴大市場佔有率,不斷豐富公司產品品類、提升產品品質、提高產能,進一步滿足市場需求,為公司未來持續穩定發展奠定堅實的基礎,公司與徐州高新技術產業開發區管理委員會(以稱“徐州高新區管委會”)擬簽署《投資協議書》。本項目總投資約20億人民幣(包含流動資金7.9億元),由兩個部分組成,第一部分為新能源電力裝備產業基地(稱“產業基地”),就產業基地,公司與徐州高新區管委會擬簽署《投資協議書》(稱“產業基地投資協議”)對相關事項作具體約定;第二部分為新能源電力裝備配套設備產業基地(稱“配套產業基地”)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.